Information Library
White Papers
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Realizing the Promise of Asia-Pacific: The Region’s Strategic Shift from Outsourcing to Innovation
March 16, 2010
Long seen as merely an outsourcing destination, the Asia-Pacific region is evolving into a center of biopharmaceutical innovation. -
Regulations for Clinical Studies in Pediatric Patients in the European Union
March 10, 2010
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric -
Key Trends in Multiple Myeloma Treatment
February 26, 2010
Key Trends in Multiple Myeloma Treatment Research Summaries from the American Society of Hematologists Meeting Recent research is producing new treatment approaches for multiple myeloma -
Biomarker Trends in Breast Cancer Research
February 24, 2010
Biomarker Trends in Breast Cancer Research Research Summaries from the San Antonio Breast Cancer Symposium As our knowledge of biomarkers increases, new studies are uncovering -
Data Driven Patient Recruitment: To Deliver Qualified Patients, Faster
February 23, 2010
Quintiles examines the extraordinary opportunity for the biopharmaceutical industry as electronic health data paves the way for a more efficient, scalable way to recruit patients for clinical trials. -
New Voices, New Opportunities: Toward a Patient-Centric Biopharmaceutical Commercialization Model
February 19, 2010
Biopharmaceutical companies must learn to navigate the increasingly tricky waters of commercializing products by adjusting to the needs of a new set of stakeholders. -
The New Health
January 19, 2010
Quintiles examines the complex challenges and opportunities facing the biopharmaceutical industry and how companies must manage risk, demonstrate greater value and improve patient outcomes. -
New FDA Guidance on Antidiabetic Therapies
December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program. -
Chasing Influenza
November 30, 2009
The rise in influenza strains like H1N1 — and the demand for new vaccines — signals a new era in vaccines. Learn how flu vaccines have evolved and where they’re headed. -
Shaping Clinical Transformation
November 18, 2009
A summary of key insights exchanged between pharma executives at the inaugural Quintiles Consulting Executive Vision Forum.
